China Health Group Inc. (HKG:8225)

China Health Group Statistics

Total Valuation

HKG:8225 has a market cap or net worth of HKD 143.33 million. The enterprise value is 114.77 million.

Market Cap	143.33M
Enterprise Value	114.77M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:8225 has 995.35 million shares outstanding.

Current Share Class	995.35M
Shares Outstanding	995.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	46.73%
Owned by Institutions (%)	n/a
Float	288.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.39
PB Ratio	1.67
P/TBV Ratio	1.65
P/FCF Ratio	8.62
P/OCF Ratio	7.72
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.95
EV / Sales	3.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	6.90

Financial Position

The company has a current ratio of 3.23

Current Ratio	3.23
Quick Ratio	2.82
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -15.50% and return on invested capital (ROIC) is -24.43%.

Return on Equity (ROE)	-15.50%
Return on Assets (ROA)	-6.78%
Return on Invested Capital (ROIC)	-24.43%
Return on Capital Employed (ROCE)	-16.51%
Weighted Average Cost of Capital (WACC)	1.70%
Revenue Per Employee	741,669
Profits Per Employee	-328,062
Employee Count	44
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:8225 has paid 310,106 in taxes.

Income Tax	310,106
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.74% in the last 52 weeks. The beta is -0.46, so HKG:8225's price volatility has been lower than the market average.

Beta (5Y)	-0.46
52-Week Price Change	-24.74%
50-Day Moving Average	0.15
200-Day Moving Average	0.16
Relative Strength Index (RSI)	41.37
Average Volume (20 Days)	32,500

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:8225 had revenue of HKD 32.63 million and -14.43 million in losses. Loss per share was -0.01.

Revenue	32.63M
Gross Profit	13.18M
Operating Income	-14.18M
Pretax Income	-14.12M
Net Income	-14.43M
EBITDA	-13.31M
EBIT	-14.18M
Loss Per Share	-0.01

Balance Sheet

The company has 27.86 million in cash and n/a in debt, with a net cash position of 27.86 million or 0.03 per share.

Cash & Cash Equivalents	27.86M
Total Debt	n/a
Net Cash	27.86M
Net Cash Per Share	0.03
Equity (Book Value)	85.93M
Book Value Per Share	0.09
Working Capital	77.14M

Cash Flow

In the last 12 months, operating cash flow was 18.56 million and capital expenditures -1.93 million, giving a free cash flow of 16.63 million.

Operating Cash Flow	18.56M
Capital Expenditures	-1.93M
Free Cash Flow	16.63M
FCF Per Share	0.02

Margins

Gross margin is 40.39%, with operating and profit margins of -43.46% and -44.23%.

Gross Margin	40.39%
Operating Margin	-43.46%
Pretax Margin	-43.28%
Profit Margin	-44.23%
EBITDA Margin	-40.80%
EBIT Margin	-43.46%
FCF Margin	50.97%

Dividends & Yields

HKG:8225 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.07%
FCF Yield	11.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:8225 has an Altman Z-Score of 2.97 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.97
Piotroski F-Score	5